Position in TEVA
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,642,165
-$1,932,671 QoQ
Shares Held
77,986
-48.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#243
of 671 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $122,719,355 across 16 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,409,759 | $112,400,085 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
77,986 | $2,642,165 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
55,602 | $1,368,365 | |
| 4 | VTRS |
Viatris Inc
|
75,955 | $1,206,165 | |
| 5 | ZTS |
Zoetis Inc.
|
13,819 | $993,033 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
40,725 | $652,821 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
3,295 | $555,339 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
32,404 | $469,533 |
All Filings in TEVA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,642,165 | 77,986 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $4,574,836 | 151,887 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,569,643 | 146,416 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,850,139 | 141,096 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $2,234,967 | 145,411 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,169,947 | 143,827 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,619,567 | 145,370 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,149,907 | 132,302 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||